Rezolute

This program provides access to an investigational drug called ersodetug for people with tumor-associated hyperinsulinism who suffer from severe, uncontrolled low blood sugar and cannot participate in regular clinical trials. It is designed for patients whose condition is not ade…

This study is testing a new drug called ersodetug for adults with severe, hard-to-control low blood sugar caused by certain tumors. Participants will receive weekly injections of the drug for 8 weeks, in addition to their current standard treatments. The main goal is to see if th…